sb 203580 has been researched along with dexmedetomidine in 1 studies
Studies (sb 203580) | Trials (sb 203580) | Recent Studies (post-2010) (sb 203580) | Studies (dexmedetomidine) | Trials (dexmedetomidine) | Recent Studies (post-2010) (dexmedetomidine) |
---|---|---|---|---|---|
3,489 | 4 | 1,137 | 5,332 | 1,643 | 4,186 |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Chang, KC; Jeong, YS; Kim, HJ; Kim, JG; Kwon, SC; Lee, SM; Ok, SH; Sohn, JT; Sung, HJ | 1 |
1 other study(ies) available for sb 203580 and dexmedetomidine
Article | Year |
---|---|
c-Jun NHâ‚‚-terminal kinase contributes to dexmedetomidine-induced contraction in isolated rat aortic smooth muscle.
Topics: Adrenergic alpha-2 Receptor Agonists; Animals; Anthracenes; Aorta; Dexmedetomidine; Enzyme Inhibitors; Extracellular Signal-Regulated MAP Kinases; Flavonoids; Imidazoles; In Vitro Techniques; JNK Mitogen-Activated Protein Kinases; Male; Muscle Contraction; Muscle, Smooth, Vascular; p38 Mitogen-Activated Protein Kinases; Protein Isoforms; Pyridines; Rats; Rats, Sprague-Dawley | 2011 |